Toward Autonomous Production of mRNA-Therapeutics in the Light of Advanced Process Control and Traditional Control Strategies for Chromatography
Abstract
1. Introduction
1.1. Process Overview
1.2. Contol Approach for Chromatography
2. Materials and Methods
2.1. QbD-Based Process Design
2.2. Process Model
2.2.1. Continuous Twin Column Chromatography Model (CTCC)
2.2.2. Periodic Countercurrent Chromatography (PCC)
2.3. Proportional-Integral-Derivative (PID) Control
2.4. Quality Management Tools
3. Results
3.1. Critical Process Parameter Identification
3.2. Continuous Twin Column Chromatography (CTCC)
3.2.1. One-Factor-at-a-Time (OFAT)
3.2.2. Design and Control Space
3.3. Periodic Countercurrent Chromatgrapyh (PCC)
3.3.1. One-Factor-at-a-Time (OFAT)
3.3.2. Design and Control Space
3.4. Control Strategy
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- BioNTech. Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron; BioNTech: Mainz, Germany; New York, NY, USA, 2022. [Google Scholar]
- Moderna. Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron; Moderna: Cambridge, MA, USA, 2022. [Google Scholar]
- BioNTech. BioNTech Introduces First Modular mRNA Manufacturing Facility to Promote Scalable Vaccine Production in Africa; BioNTech: Mainz, Germany, 2022. [Google Scholar]
- Schmidt, A.; Helgers, H.; Vetter, F.L.; Juckers, A.; Strube, J. Digital Twin of mRNA-Based SARS-COVID-19 Vaccine Manufacturing towards Autonomous Operation for Improvements in Speed, Scale, Robustness, Flexibility and Real-Time Release Testing. Processes 2021, 9, 748. [Google Scholar] [CrossRef] [Scilit]
- Štrancar, A. High Yield mRNA Production Process from E. coli to Highly Pure mRNA. 2020. Available online: https://www.biaseparations.com/en/library/seminars-webinars/1098/high-yield-mrna-production-process-from-ecoli-to-highly-pure-mrna (accessed on 6 July 2022).
- Von der Mülbe, F.; Reidel, L.; Ketterer, T.; Gontcharova, L.; Bauer, S.; Pascolo, S.; Probst, J.; Schmid, A. Method for Producing RNA. U.S. Patent 10,017,826, 10 July 2018. [Google Scholar]
- Schmidt, A.; Helgers, H.; Vetter, F.L.; Juckers, A.; Strube, J. Fast and Flexible mRNA Vaccine Manufacturing as a Solution to Pandemic Situations by Adopting Chemical Engineering Good Practice—Continuous Autonomous Operation in Stainless Steel Equipment Concepts. Processes 2021, 9, 1874. [Google Scholar] [CrossRef] [Scilit]
- Zobel-Roos, S.; Schmidt, A.; Mestmäcker, F.; Mouellef, M.; Huter, M.; Uhlenbrock, L.; Kornecki, M.; Lohmann, L.; Ditz, R.; Strube, J. Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable Without a Digital-Twin? Processes 2019, 7, 94. [Google Scholar] [CrossRef] [Scilit]
- Helgers, H.; Hengelbrock, A.; Schmidt, A.; Strube, J. Digital Twins for Continuous mRNA Production. Processes 2021, 9, 1967. [Google Scholar] [CrossRef] [Scilit]
- GenScript ProBio. Accelerating Vaccine Development against COVID-19. 2020. Available online: https://www.genscriptprobio.com/gsfiles/techfiles/GPB-COVID19-GMP%20plasmid-GPB_052020.pdf (accessed on 8 July 2022).
- Kis, Z.; Kontoravdi, C.; Shattock, R.; Shah, N. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2020, 9, 3. [Google Scholar] [CrossRef] [Scilit]
- Klatt, K.-U.; Hanisch, F.; Dünnebier, G.; Engell, S. Model-based optimization and control of chromatographic processes. Comput. Chem. Eng. 2000, 24, 1119–1126. [Google Scholar] [CrossRef] [Scilit]
- Toumi, A.; Engell, S. Optimization-based control of a reactive simulated moving bed process for glucose isomerization. Chem. Eng. Sci. 2004, 59, 3777–3792. [Google Scholar] [CrossRef] [Scilit]
- Engell, S.; Toumi, A. Optimisation and control of chromatography. Comput. Chem. Eng. 2005, 29, 1243–1252. [Google Scholar] [CrossRef] [Scilit]
- Grossmann, C.; Ströhlein, G.; Morari, M.; Morbidelli, M. Optimizing model predictive control of the chromatographic multi-column solvent gradient purification (MCSGP) process. J. Process Control 2010, 20, 618–629. [Google Scholar] [CrossRef] [Scilit]
- Espinoza, D.; Andersson, N.; Nilsson, B. Binary separation control in preparative gradient chromatography using iterative learning control. J. Chromatogr. A 2022, 1673, 463078. [Google Scholar] [CrossRef] [Scilit]
- Armstrong, A.; Horry, K.; Cui, T.; Hulley, M.; Turner, R.; Farid, S.S.; Goldrick, S.; Bracewell, D.G. Advanced control strategies for bioprocess chromatography: Challenges and opportunities for intensified processes and next generation products. J. Chromatogr. A 2021, 1639, 461914. [Google Scholar] [CrossRef] [Scilit]
- European Medicines Agency. ICH Guideline Q11 on Development And Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities); European Medicines Agency: Amsterdam, The Netherlands, 2012. [Google Scholar]
- European Medicines Agency. ICH Guideline Q8 (R2) on Pharmaceutical Development; European Medicines Agency: Amsterdam, The Netherlands, 2017. [Google Scholar]
- CMC Biotech Working Group. A-Mab: A Case Study in Bioprocess Development. 2009. Available online: https://qbdworks.com/storage/2014/06/A-MabCaseStudyVersion.pdf (accessed on 8 July 2022).
- Guiochon, G.; Felinger, A.; Shirazi, D.G.; Katti, A.M. Fundamentals of Preparative and Nonlinear Chromatography, 2nd ed.; Elsevier Academic Press: Amsterdam, The Netherlands; ISBN 9780123705372.
- Papathanasiou, M.M.; Steinebach, F.; Stroehlein, G.; Müller-Späth, T.; Nascu, I.; Oberdieck, R.; Morbidelli, M.; Mantalaris, A.; Pistikopoulos, E.N. A control strategy for periodic systems–application to the twin-column MCSGP. In 12th International Symposium on Process Systems Engineering and 25th European Symposium on Computer Aided Process Engineering; Elsevier: Amsterdam, The Netherlands, 2015; pp. 1505–1510. ISBN 9780444634290. [Google Scholar]
- Aumann, L.; Morbidelli, M. A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process. Biotechnol. Bioeng. 2007, 98, 1043–1055. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Persson, O.; Andersson, N.; Nilsson, B. Design of two-column batch-to-batch recirculation to enhance performance in ion-exchange chromatography. J. Chromatogr. A 2018, 1531, 112–121. [Google Scholar] [CrossRef] [Scilit]
- Ziegler, J.G.; Nichols, N.B. Optimum Settings for Automatic Controllers. J. Dyn. Syst. Meas. Control 1993, 115, 220–222. [Google Scholar] [CrossRef] [Scilit]
- Zacher, S.; Reuter, M. Regelungstechnik für Ingenieure; Springer Fachmedien Wiesbaden: Wiesbaden, Germany, 2017; ISBN 978-3-658-17631-0. [Google Scholar]
- Chien, K.L.; Hrones, J.; Reswick, J.B. On the Automatic Control of Generalized Passive Systems. Trans. Am. Soc. Mech. Eng. 1952, 74, 175–185. [Google Scholar] [CrossRef] [Scilit]
- Ishikawa, K. Guide to Quality Control, 13th ed; Asian Productivity Organization: Tokyo, Japan, 1996; ISBN 92-833-1036-5. [Google Scholar]
- Vetter, F.L.; Zobel-Roos, S.; Strube, J. PAT for Continuous Chromatography Integrated into Continuous Manufacturing of Biologics towards Autonomous Operation. Processes 2021, 9, 472. [Google Scholar] [CrossRef] [Scilit]
- Zobel-Roos, S.; Mouellef, M.; Ditz, R.; Strube, J. Distinct and Quantitative Validation Method for Predictive Process Modelling in Preparative Chromatography of Synthetic and Bio-Based Feed Mixtures Following a Quality-by-Design (QbD) Approach. Processes 2019, 7, 580. [Google Scholar] [CrossRef] [Scilit]
- Helling, C.; Dams, T.; Gerwat, B.; Belousov, A.; Strube, J. Physical characterization of column chromatography: Stringent control over equipment performance in biopharmaceutical production. Trends Chromatogr. 2013, 8, 55–71. [Google Scholar]
- Zobel-Roos, S.; Mouellef, M.; Siemers, C.; Strube, J. Process Analytical Approach towards Quality Controlled Process Automation for the Downstream of Protein Mixtures by Inline Concentration Measurements Based on Ultraviolet/Visible Light (UV/VIS) Spectral Analysis. Antibodies 2017, 6, 24. [Google Scholar] [CrossRef] [Scilit]
- Mendhe, R.; Thukkaram, M.; Patil, N.; Rathore, A.S. Comparison of PAT based approaches for making real-time pooling decisions for process chromatography-use of feed forward control. J. Chem. Technol. Biotechnol. 2015, 90, 341–348. [Google Scholar] [CrossRef] [Scilit]
- Mouellef, M.; Szabo, G.; Vetter, F.L.; Siemers, C.; Strube, J. Artificial Neural Network for Fast and Versatile Model Parameter Adjustment Utilizing PAT Signals of Chromatography Processes for Process Control under Production Conditions. Processes 2022, 10, 709. [Google Scholar] [CrossRef] [Scilit]
- Mouellef, M.; Vetter, F.L.; Zobel-Roos, S.; Strube, J. Fast and Versatile Chromatography Process Design and Operation Optimization with the Aid of Artificial Intelligence. Processes 2021, 9, 2121. [Google Scholar] [CrossRef] [Scilit]


















| Impact | Critical Quality Attribute (CQA) | Process Attribute |
|---|---|---|
| No Impact/Interaction | 1 | 1 |
| Minor Impact/Interaction | 4 | 2 |
| Major Impact/Interaction | 8 | 4 |
| Phase | Parameter | Range | Main Effect | Main Effect | Highest Main | Interaction | Interaction | Highest | Severity | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min | Sim | Max | Unit | CQA (Purity) | PA (PR/Y) | Effect Score | CQA (Purity) | PA (PR/Y) | Interaction Score | |||
| All Phases | Column bed height | 8 | 10 | 12 | cm | 8 | 4 | 8 | 1 | 4 | 4 | 32 |
| Column diameter | 20 | 27 | 100 | cm | 1 | 1 | 1 | 4 | 4 | 4 | 4 | |
| Fluiddynamics: Dax | 0 | 0 | 0 | - | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Fluiddynamics: Epsilon | 0.3 | 0.36 | 0.4 | - | 8 | 2 | 8 | 4 | 2 | 4 | 32 | |
| Temperature | 20 | 22 | 25 | °C | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Pressure | 0 | 30 | bar | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Equilibration | Flow rate | 100 | 300 | cm/h | 1 | 4 | 4 | 1 | 2 | 2 | 8 | |
| Buffer salt concentration | 0.05 | 0.05 | 0.25 | mol/L | 8 | 2 | 8 | 1 | 2 | 2 | 16 | |
| Loading | Flow rate | 100 | 300 | cm/h | 1 | 4 | 4 | 1 | 2 | 2 | 8 | |
| Salt concentration | 0.05 | 0.05 | 0.25 | mol/L | 1 | 8 | 8 | 1 | 2 | 2 | 16 | |
| Injection volume | 2 | 4 | 4 | CV | 8 | 2 | 8 | 1 | 2 | 2 | 16 | |
| Feed concentration | 4 | 7.5 | 7.5 | g/L | 8 | 2 | 8 | 1 | 2 | 2 | 16 | |
| Wash | Flow rate | 100 | 300 | cm/h | 1 | 2 | 2 | 1 | 2 | 2 | 4 | |
| Buffer salt concentration | 0.05 | 0.05 | 0.75 | mol/L | 8 | 2 | 8 | 1 | 2 | 2 | 16 | |
| Elution | Flow rate | 100 | 300 | cm/h | 1 | 2 | 2 | 4 | 2 | 4 | 8 | |
| Salt concentration start | 0.05 | 0.05 | 0.25 | mol/L | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Salt concentration end | 1.5 | 2 | 2 | mol/L | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Gradient | 3 | 5 | 10 | CV | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Start fractionation | 0.5 | 0.5 | 1.5 | g/L | 1 | 2 | 2 | 4 | 2 | 4 | 8 | |
| Volume product | 0.5 | 1 | 1.5 | CV | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Volume fraction 1 | 0 | 0.1 | 0.5 | CV | 8 | 4 | 8 | 8 | 4 | 8 | 64 | |
| Volume fraction 2 | 0 | 0.25 | 0.5 | CV | 8 | 2 | 8 | 1 | 2 | 2 | 16 | |
| Parameter | Min | Center | Max |
|---|---|---|---|
| /mL | 3.5 | 4 | 4.5 |
| /g/L | 6.5 | 7.5 | 8.5 |
| /g/L | 0.047 | 0.050 | 0.053 |
| /g/L | 1.9 | 2 | 2.1 |
| Gradient length/CV | 4.7 | 5 | 5.3 |
| Length fraction 1/CV | 0.04 | 0.05 | 0.06 |
| Product fraction/CV | 0.8 | 0.9 | 1 |
| Length fraction 2/CV | 0.25 | 0.3 | 0.35 |
| Epsilon/- | 0.3 | 0.35 | 0.4 |
| Phase | Parameter | Range | Main Effect | Main Effect | Highest Main | Interaction | Interaction | Highest | Severity | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Min | Sim | Max | Unit | CQA (Purity) | PA (PR/Y) | Effect Score | CQA (Purity) | PA (PR/Y) | Interaction Score | |||
| All Phases | Column bed height | 5 | 10 | 15 | cm | 1 | 4 | 4 | 4 | 2 | 4 | 16 |
| Column diameter | 15 | 17.8 | 30 | cm | 1 | 4 | 4 | 4 | 2 | 4 | 16 | |
| Fluiddynamics: Dax | 2 × 10−4 | 0 | 0.02 | - | 1 | 2 | 2 | 1 | 2 | 2 | 4 | |
| Fluiddynamics: Epsilon | 0.36 | 0.56 | 0.56 | - | 1 | 2 | 2 | 1 | 2 | 2 | 4 | |
| Temperature | 20 | 22 | 25 | °C | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Pressure | 0 | 30 | bar | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Flow rate | 500 | 1000 | 1000 | cm/h | 1 | 4 | 4 | 1 | 4 | 4 | 16 | |
| Equilibration | Equilibration length | 0.1 | 0.5 | 1 | CV | 1 | 2 | 2 | 1 | 1 | 1 | 2 |
| Acetonitrile Conc | 0.1 | 0.13 | 0.15 | v/v | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Feed | Acetonitrile Conc | 0.1 | 0.13 | 0.15 | v/v | 1 | 2 | 2 | 1 | 1 | 1 | 2 |
| Feed concentration | 3 | 4.3 | 7 | g/L | 1 | 4 | 4 | 1 | 2 | 2 | 8 | |
| Switching criteria | 50 | 75 | 100 | % | 1 | 2 | 2 | 1 | 2 | 2 | 4 | |
| Wash | Wash length | 0 | 3 | 3 | CV | 8 | 4 | 8 | 1 | 2 | 2 | 16 |
| Acetonitrile Conc | 0.1 | 0.13 | 0.15 | v/v | 1 | 4 | 4 | 1 | 4 | 4 | 16 | |
| Gradient | Acetonitrile Conc Start | 0.1 | 0.13 | 0.15 | v/v | 1 | 2 | 2 | 1 | 1 | 1 | 2 |
| Acetonitrile Conc End | 0.3 | 0.35 | 0.4 | v/v | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Gradient | 0.1 | 1 | 1 | CV | 1 | 2 | 2 | 2 | 2 | 2 | 4 | |
| Start fractionation | 0.1 | 0.1 | 1 | g/L | 1 | 4 | 4 | 1 | 4 | 4 | 16 | |
| CQA/KPP | Batch | PCC |
|---|---|---|
| Purity | ||
| Yield | ||
| Productivity |
| CQA/KPP | Batch Process | CTCC | CTCC Soft Sensor/MPC |
|---|---|---|---|
| Purity | |||
| Yield | |||
| Productivity |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Vetter, F.L.; Zobel-Roos, S.; Mota, J.P.B.; Nilsson, B.; Schmidt, A.; Strube, J. Toward Autonomous Production of mRNA-Therapeutics in the Light of Advanced Process Control and Traditional Control Strategies for Chromatography. Processes 2022, 10, 1868. https://doi.org/10.3390/pr10091868
Vetter FL, Zobel-Roos S, Mota JPB, Nilsson B, Schmidt A, Strube J. Toward Autonomous Production of mRNA-Therapeutics in the Light of Advanced Process Control and Traditional Control Strategies for Chromatography. Processes. 2022; 10(9):1868. https://doi.org/10.3390/pr10091868
Chicago/Turabian StyleVetter, Florian Lukas, Steffen Zobel-Roos, José Paulo Barbosa Mota, Bernt Nilsson, Axel Schmidt, and Jochen Strube. 2022. "Toward Autonomous Production of mRNA-Therapeutics in the Light of Advanced Process Control and Traditional Control Strategies for Chromatography" Processes 10, no. 9: 1868. https://doi.org/10.3390/pr10091868
APA StyleVetter, F. L., Zobel-Roos, S., Mota, J. P. B., Nilsson, B., Schmidt, A., & Strube, J. (2022). Toward Autonomous Production of mRNA-Therapeutics in the Light of Advanced Process Control and Traditional Control Strategies for Chromatography. Processes, 10(9), 1868. https://doi.org/10.3390/pr10091868

